Se-A Lee

Se-A Lee

Auto-generated profile, based on publicly available information

Se-A Lee

Viral Disease Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JLJienny Lee
Jienny Lee
SLSe-A Lee
Se-A Lee
NGNa-Yeon Gu
Na-Yeon Gu
SJSo Yeon Jeong
So Yeon Jeong
JBJeong Su Byeon
Jeong Su Byeon
BHBang-Hun Hyun
Bang-Hun Hyun
Natural killer (NK) cells are key immune cells engaged in fighting infection and malignant transformation. In this study, we found that canine NK cell‐derived exosomes (NK‐exosomes) separated from activated cytotoxic NK cell supernatants express specific markers including CD63, CD81, Alix, HSP70, TSG101, Perforin 1, and Granzyme B. We examined the antitumor effects of NK‐exosomes in an experimental murine mammary tumor model using REM134 canine mammary carcinoma cell line. We observed changes in tumor size, tumor initiation, progression, and recurrence‐related markers in the control, tumor group, and NK‐exosome‐treated tumor group. We found that the tumor size in the NK‐exosome‐treated tumor group decreased compared with that of the tumor group in the REM134‐driven tumorigenic mouse model. We observed significant changes including the expression of tumorigenesis‐related markers, such as B cell‐specific Moloney murine leukemia virus insertion site 1 (Bmi‐1), vascular endothelial growth factor (VEGF), matrix metallopeptidase‐3 (MMP‐3), interleukin‐1β (IL‐1β), IL‐6, tumor necrosis factor‐α (TNF‐α), multidrug resistance protein (MDR), tumor suppressor protein p53 (p53), proliferating cell nuclear antigen (PCNA), and the apoptotic markers, B cell lymphoma‐2 associated X (Bax) and B cell lymphoma‐extra large (Bcl‐xL) belonging to the Bcl‐2 family, in the tumor group compared with those in the control group. The expression of CD133, a potent cancer stem cell marker, was significantly higher than that of the control. By contrast, the NK‐exosome‐treated tumor group exhibited a significant reduction in Bmi‐1, MMP‐3, IL‐1β, IL‐6, TNF‐α, Bax, Bcl‐xL, and PCNA expression compared with that in the tumor group. Furthermore, the expression of CD133, which mediates tumorigenesis, was significantly decreased in the NK‐exosome‐treated tumor group compared with that in the tumor group. These findings indicate that canine NK‐exosomes represent a promising therapeutic tool against canine solid tumors, including mammary carcinoma.

1 January 2023 in Journal of Veterinary Science
Verified
Journal Article
Open access
PDF file
SLSe-A Lee
Se-A Lee
HLHye Jeong Lee
Hye Jeong Lee
NGNa-Yeon Gu
Na-Yeon Gu
YPYu-Ri Park
Yu-Ri Park
EKEun-Ju Kim
Eun-Ju Kim
DYDong-Kun Yang
Dong-Kun Yang
Lee SA, et al. J Vet Sci. 2023 Jul;24:e53. https://doi.org/10.4142/jvs.23017